Sodium valproate and valproic acid surface to lower barbiturate metabolism; consequently, barbiturate blood ranges should be monitored and suitable dosage adjustments built as indicated. If this SPL includes inactivated NDCs stated by the FDA initiated compliance action, they will be specified therefore. the greater lipid soluble the barbiturate,